ArticleJournal of neuro-oncology2026
DTI-ALPS is not independently associated with overall survival beyond established prognostic factors in glioblastoma.
Article in Journal of neuro-oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeImpaired glymphatic function has been associated with shorter survival in glioblastoma. However, the relationship between glymphatic dysfunction and survival has not yet been evaluated in the context of established prognostic factors, including extent of resection, adjuvant therapy, MGMT promoter methylation status, and clinical performance status.
methodsSingle-center retrospective study including patients undergoing surgery for unifocal glioblastoma IDHwt CNS WHO grade 4 (GBM), with preoperative DTI studies in comparison to healthy controls (HC). Glymphatic impairment was assessed using diffusion tensor imaging analysis along the perivascular space (DTI-ALPS), which is an accepted surrogate marker for glymphatic function. This study follows the STROBE guidelines for cohort studies.
resultsWe included 47 patients with GBM and 50 HC. The hemispherically averaged ALPS index was lower in GBM patients (1.15 vs. 1.27, p = 0.01). There were no differences between contralateral ALPS and HC (1.22 vs. 1.27, p = 0.29). Ipsilateral ALPS was lower compared to HC (1.05 vs. 1.27, p < 0.001) and to the contralateral hemisphere (1.1 vs. 1.22, p = 0.01). Univariable Cox regression showed no association between overall survival and ALPS parameters (ipsilateral HR 2.25 95% CI 0.49-10.31 p = 0.3, contralateral HR 2.96 95% CI 0.57-15.32 p = 0.2). In multivariate analysis significant associations were found for female and extent of resection but not for MGMT status, age, ipsi- or contralateral ALPS indices.
conclusionIn patients with GBM, glymphatic function might be impaired as expressed by decreased ALPS index in the ipsilateral hemisphere. Ipsi- or contralateral ALPS index reduction did not predict overall survival independent of known predictors. Because DTI-ALPS has inherent limitations, further investigation of glymphatic dysfunction using different methods in glioblastoma is warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.